Introduction
Since 1990, maternal and child mortality rates have fallen by about half, with the largest reductions occurring since 2000. 1 However, only a third of countries with the greatest mortality burden (the 75 Countdown priority countries) achieved Millennium Development Goal 4 (MDG 4; to reduce the mortality rate in children younger than 5 years by two-thirds between 1990 and 2015), and only 6% achieved MDG 5 (to reduce the maternal mortality ratio by three-quarters). 1 Part of the mortality reductions achieved has been attributed to increased coverage of life-saving interventions. 2 Although vaccination coverage and malaria intervention coverage have increased substantially, coverage of family planning and safe motherhood interventions remain inadequate, and wide inequalities in coverage persist. 1 Availability of adequate fi nancial resources is a factor enabling progress towards improved health outcomes, through funding quality health services. [3] [4] [5] In many low-income countries, donor funding represents a substantial share of health sector fi nancing, amounting to an average of 33% of total health expenditure across all low-income countries in 2013. 6 As part of the Countdown initiative, we have tracked aid fl ows to maternal, newborn, and child health, reporting fi ndings every 2 years since 2006. From its original focus on tracking aid fl ows to maternal, newborn, and child health, our resource tracking exercise extended in 2009 to include reproductive and sexual health (reproductive, maternal, newborn, and child health). Since we began tracking resource fl ows, the Institute for Health Metrics and Evaluation (IHME) has begun tracking development assistance to the health sector 7 and the Partnership for Maternal, Newborn and Child Health tracks aid to reproductive, maternal, newborn, and child health. 8 The resource fl ows project of the United Nations Population Fund (UNFPA) and the Netherlands Interdisciplinary Demographic Institute, tracking international population assistance, has been underway since 2002, 9 and the Organisation for Economic Co-operation and Development recently began requesting that donors report on a reproductive, maternal, newborn, and child health policy marker as part of their offi cial reporting. Unlike other initiatives, we take a detailed approach to resource tracking, coding record by record with the use of project descriptions, based on a clear conceptual framework and coding scheme. This enables us to maintain a highly disaggregated classifi cation of projects and to estimate the full value of resources benefi ting reproductive, maternal, newborn, and child health, including a proportion of aid to the health sector, and to the humanitarian and other sectors. [10] [11] [12] [13] [14] [15] [16] This study presents an overview of trends in funding to reproductive, maternal, newborn, and child health over the period . Using data reported by donors in 2015, we provide estimates for 2013 and updated estimates for 2003-12, including complete trends in reproductive and sexual health, which had previously only been reported from 2009. We present global trends, focusing particularly on the 75 Countdown priority recipient countries, where over 95% of all maternal and child deaths occur, and assess trends in targeting to health need. 17, 18 We refl ect on fi ndings over the period 2003-13 and at the end of the MDG era, to inform accountability exercises related to the Sustainable Development Goals.
Methods

Study design
We downloaded offi cial development assistance (ODA) disbursement data for the period 2003-13 from the creditor reporting system of the Organisation for Economic Co-operation and Development on Jan 7, 2015. We obtained data for disbursements made by the Global Alliance for Vaccines and Immunization (GAVI) for 2003-06 directly from GAVI as they were not available through the creditor reporting system (Mocova D, GAVI, personal communication). We tracked disbursements to all recipient countries (147 countries in 2013, plus 17 regional recipients and unspecifi ed bilateral disbursements) from all donors reporting ODA disbursements to the creditor reporting system (64 donors in 2013) and from the Bill & Melinda Gates Foundation, which has reported disbursements to the creditor reporting system from 2009 onwards. Although we considered private grants rather than ODA, we included Bill & Melinda Gates Foundation grants in our analyses and we refer to ODA+ when reporting results that include these grants. Other offi cial fl ows were excluded.
We classifi ed aid by donor type, using the Organisation for Economic Co-operation and Development defi nitions to avoid double counting. We classifi ed as bilateral aid
Research in context
Evidence before this study We searched for published literature in Pubmed using the terms: global AND ("external funding" OR "resource tracking" OR "offi cial development assistance") AND (maternal OR reproductive OR child OR newborn) for the period 2003-2016. We also reviewed Institute of Health Metrics and Evaluation (IHME), Partnership for Maternal, Newborn and Child Health (PMNCH) and the United Nations Population Fund (UNFPA) and the Netherlands Interdisciplinary Demographic Institute (NIDI) reports on aid fl ows, downloaded from the IHME, WHO and Resource Flows project websites. Several estimates exist of offi cial development assistance plus grants from the Bill & Melinda Gates Foundation (ODA+) to reproductive, maternal, newborn and child health, including the past publications of the Countdown project, two studies examining external funding to reproductive health in confl ict-aff ected settings, and estimates from the Institute for Health Metrics and Evaluation, Partnership for Maternal, Newborn and Child Health and UNFPA/NIDI. Past Countdown publications have not previously included updated estimates of ODA+ from previous years.
Added value of this study
This study extends the analysis of ODA+ to reproductive, maternal, newborn and child health to include disbursements made in 2013, disbursements made in 2003-12 but reported later, and corrections to inconsistencies in coding over the whole period of the Countdown project. This has resulted in a complete dataset of ODA+ disbursements for reproductive, maternal, newborn, and child health for the period 2003-13, as reported to the Organisation for Economic Co-operation and Development creditor reporting system, allowing for the fi rst time analyses of trends in complete ODA+ to reproductive, maternal, newborn, and child health for the full period.
Implications of all the available evidence
We found that ODA+ for reproductive, maternal, newborn, and child health increased alongside ODA+ to the health sector, and faster than overall increases in ODA+. Increases have been greatest for child health, mainly relating to immunisation, and reproductive and sexual health, primarily relating to HIV; increases for maternal and newborn health have been smaller. Targeting to health need seems to have improved among recipient countries, particularly from 2009 to 2013. Diff erent tracking exercises give a wide range of estimates.
For more on the creditor reporting system see https://stats.oecd.org/Index. aspx?DataSetCode=CRS1 disbursements for which the donor country specifi es the recipient country or purpose of aid, and as multilateral aid disbursements by multilateral institutions where the multilateral institution specifi es the recipient country or purpose of aid. We allocated unspecifi ed regional disbursements to countries within the given region based on their year-specifi c share of direct regional disbursements to reproductive, maternal, newborn, and child health. 13 Where the recipient was reported as "bilateral, unspecifi ed", we included disbursements by allocating shares of such disbursements to each country receiving direct disbursements, based on their yearspecifi c shares of direct disbursements.
Data coding
Our coding framework classifi es activities into 27 Countdown codes according to the degree to which they respectively benefi t reproductive and sexual health, maternal and newborn health, and child health. Reproductive and sexual health expenditures are defi ned as expenditures on family planning, sexual health, and sexually transmitted infections, including HIV. 12 Maternal and newborn health expenditures cover activities to restore, improve, and maintain the health of women and their newborn babies during pregnancy, childbirth, and the fi rst month of life. 16 Expenditures for child health include activities to restore, improve, and maintain the health of children up to 5 years of age. 16 Where age was not specifi ed, "child" was assumed to refer to children aged under 5 years. Funding for research activities was excluded.
We included funds explicitly earmarked for reproductive, maternal, newborn, and child health and funds for other activities considered to benefi t reproductive, maternal, newborn, and child health, such as funds for health system strengthening, general healthcare provision, general budget support, and basket or sector funding, as well as some health-condition-specifi c funding-eg, funding for malaria and HIV. Funds to these broader expenditure categories were allocated to reproductive, maternal, newborn, and child health based on a set of rules refl ecting the proportion of the disbursement considered to benefi t reproductive, maternal, newborn, and child health (appendix p 1). For condition-specifi c funding, country-specifi c and regionspecifi c rules were based on the proportion of the population aged younger than 5 years (malaria, other infectious diseases, and conditions aff ecting general population health); the proportion of people living with HIV who were children aged younger than 5 years and women aged 15 years or older (general HIV support); and the prevalence of women aged 15-49 among people living with any of four sexually transmitted infections (Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema pallidum, and Trichomonas vaginalis). 12 For general budget support, the rule was based on the proportion of government spending that goes to health and was obtained from the National Health Accounts database. 6 The allocation of health systems funds and basket or sector funding to reproductive, maternal, newborn, and child health was the same for all countries, with estimates of spending related to reproductive, maternal, newborn, and child health based on the scientifi c literature. 16 We reviewed and coded 231 398 disbursement records for the year 2013 across all sectors according to a previously developed framework. 12, 16 The only addition to the coding method used previously in Countdown analyses was that in this iteration, fl ags were added to the data to be coded to indicate the presence of key terms related to the reproductive, maternal, newborn, and child health codes to be assigned. These fl ags were generated through searches for terms in the three descriptive fi elds-project title, short description, and long description-and used to indicate that a record was likely to be related to a particular Countdown code. This aimed to reduce the cognitive load and increase the speed of manual review, and all records were manually coded regardless of the presence of fl ags. Where there was any ambiguity in coding, we clarifi ed and revised the coding framework (appendix p 2). To create a fully coded dataset for 2003-13, we combined these records with records coded in previous rounds of the Countdown project, covering 2003-12. As the reproductive and sexual health codes were used only from 2009 onwards, we also revisited disbursement records for the years 2003-08 across all sectors, and re-coded those eligible for a reproductive and sexual health activity code.
Donors not only add disbursement data to the creditor reporting system database but also might change previously reported disbursements for earlier years. Until now, analyses of disbursement trends did not comprehensively update previous analyses to account for these changes, nor were thorough consistency checks undertaken to compare the assignment of codes over time. [10] [11] [12] [13] [14] 16 In each of the six rounds of coding, usually one, but up to four researchers, coded the newest 1 or 2 years of data. To ensure coding consistency over time we identifi ed records within the Countdown database that were identical on fi ve fi elds (creditor reporting system purpose code, project title, short description, long description, and donor), but had been assigned diff erent Countdown codes. We identifi ed 82 150 discrepant records in 6616 unique groups of records that were identical on the fi ve fi elds. Where one record in a group related to a 2013 disbursement, all records in that group were assigned the 2013 code; where all discrepant records in a group related to disbursements between 2003-12, CG or LA reviewed and reconciled codes.
To update the Countdown database for the period 2003-13, we matched the Countdown database to the creditor reporting system dataset downloaded in January 2015 on the fi ve fi elds. 137 909 records in the 2015 creditor reporting system had a null or See Online for appendix zero disbursement value and were coded zero. Where records in the 2015 creditor reporting system were successfully matched on the fi ve fi elds, they were assigned the code from the Countdown database; 1 428 027 records were coded in this way. We manually coded the remaining 556 587 unmatched records. We also obtained and coded 1190 records directly from GAVI for the period 2003-06 and added them to the fi nal dataset. We checked the resulting dataset of 2 123 713 coded records for 2003-13 for coding inconsistencies identifi ed during the dataset preparation and corrected codes for 11 136 records. For example, we found that vaccination for yellow fever had in some years been coded as only benefi ting children (code 415); such records were assigned the correct code for vaccinations benefi tting the general population (436; appendix p 2). The fully coded dataset is available online.
Statistical analysis
We analysed trends in ODA+ and ODA+ to the health sector over the period 2003-13. ODA+ to the health sector was defi ned as funding falling under the following purpose codes in the Creditor Reporting System: Health (code 120) and Population Policies, Programmes, and Reproductive Health (code 130). All creditor reporting system purpose codes are listed online. Unlike our estimates of ODA+ to reproductive, maternal, newborn, and child health, the estimate of ODA+ to health does not include ODA+ benefi ting health reported to other sectors. We analysed trends in donor funding to reproductive, maternal, newborn, and child health for the period 2003-13. We examined variation in reproductive, maternal, newborn, and child health funding amounts over time by donor and donor type (bilateral, multilateral, global health initiative, and private foundation); by funding modality (pooled funding versus project funding) and project type; and by recipient countries and regions. Data were transferred to Microsoft SQL Server Management Studio for data management. Data were exported to Microsoft Excel for coding. Disbursement data were converted to constant 2013 US dollars using the donor-specifi c Development Assistance Committee defl ators.
We explored whether donors targeted their ODA+ to countries with the greatest health needs and whether targeting changed over time. For each of the years 2003-13, we calculated Spearman's correlation between ODA+ to child health per child and mortality in children younger than 5 years, ODA+ to maternal and newborn health per birth and maternal mortality, ODA+ to reproductive and sexual health per woman of reproductive age and HIV prevalence, and ODA+ to reproductive and sexual health per woman of reproductive age and female life expectancy at birth. We obtained data for mortality in children younger than 5 years, maternal mortality, HIV prevalence, and female life expectancy from the World Bank's World Development Indicators, and population data from the UN World Population Prospects. 19 Rather than pick an arbitrary lag period, we used disbursements and healthneed indicators from the same year.
Role of the funding source
The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility to submit for publication.
Results
Total ODA+ to all sectors was estimated at US$161 billion in 2013, with ODA+ to the health sector at $24 billion (15% of total ODA+), a 10% and 12% increase relative to 2012, respectively (fi gure 1). Over the period 2003-13, total ODA+ to all sectors more than doubled (increase of 108%) and ODA+ to the health sector increased more than three-fold (219%), with an increase in the share of ODA+ allocated to the health sector over time (from 10% in 2003 to 15% in 2013; appendix p 4).
Total ODA+ to reproductive, maternal, newborn, and child health reached almost US$14·0 billion in 2013, of which 48% supported child health ($6·8 billion), 34% supported reproductive and sexual health ($4·7 billion), and 18% maternal and newborn health (US$2·5 billion; appendix p 5). ODA+ to reproductive, maternal, newborn, and child health in 2013 was 11% higher than that in 2012, with the greatest increase in child health (18%) and the lowest for reproductive and sexual health (6%). Over the period 2003-13, ODA+ to reproductive, maternal, newborn, and child health more than tripled, increasing by 225%.
ODA+ to reproductive, maternal, newborn, and child health and ODA+ to the health sector increased at a similar rate over the period 2003-13. In 2013, 94% of the value of our estimate of ODA+ to reproductive, maternal, newborn, and child health came from funding to the health sector (within the 120 and 130 purpose codes); this proportion increased slightly over time, ranging from 87-89% in 2003-06 and 90-94% in 2007-13 (data not shown). Child health received the most substantial increase in funding over the period 2003-13 (286%), followed by reproductive and sexual health (194%), and maternal and newborn health (164%).
In 2013, bilateral donors disbursed 59% of all ODA+ to reproductive, maternal, newborn, and child health, followed by global health initiatives (23%), and multilaterals (13%; table 1, appendix p 5). The top four donors for reproductive, maternal, newborn, and child health over the period 2003-13 were the USA (US$32 billion), the Global Fund ($11 billion), the UK ($7·3 billion), and GAVI ($6·6 billion; appendix p 8). These were also the four largest donors in 2013 (fi gure 2, table 1). Bilateral funding grew three-fold, and multilateral funding increased 1·5-fold over the period 2003-13. The UK and Canada increased their ODA to reproductive, maternal, newborn, and child health fourfold over this period, the largest relative increase among bilateral donors. Most Scandinavian countries (Sweden, Denmark, and Finland) decreased their ODA to reproductive, maternal, newborn, and child health, as did the European economies worst aff ected by the global fi nancial crisis, notably Greece and Spain. The only large increase among multilateral donors was the seven-fold increase from the European Union institutions. Global health initiatives increased funding more than nine-fold, with a 13-fold increase from the Global Fund and a six-fold increase from GAVI (appendix p 6).
ODA+ to the health sector and to reproductive, maternal, newborn, and child health has been concentrated in the 75 priority countries (fi gure 3, appendix p 8). Among the Countdown priority countries, ODA+ to reproductive, maternal, newborn, and child health increased between 2012 and 2013 (by 12%), whereas among the non-priority countries it fell for reproductive and sexual health (-6%), maternal and newborn health (-6%), and child health (-2%). A greater share of ODA+ received by the 75 priority countries was disbursed to the health sector compared with nonpriority countries (18% vs 11%), and ODA+ to the health sector increased more in priority countries over the period 2003-13 than in non-priority countries (243% vs 176%). The ratio of reproductive, maternal, newborn, and child health ODA+ to health sector ODA+ was higher in the priority countries than in other countries (78% vs 12%). The growth in ODA+ to reproductive and sexual health, maternal and newborn health, and child health over the period 2003-13 was also much greater in priority than non-priority countries: 205% versus 90% for reproductive and sexual health, 305% versus 128% for child health, and 190% versus 31% for maternal and newborn health. Similar to previous years, in 2013, of the 75 priority countries, Nigeria, Ethiopia, and Kenya received the largest total disbursements of ODA+ to reproductive, maternal, newborn, and child health, while Equatorial Guinea, Turkmenistan, and Gabon received the smallest (table 2; appendix p 8). Over the period 2003-13, Equatorial Guinea and Brazil experienced the largest reductions in ODA+ to reproductive, maternal, newborn, and child health (-80% and -74%, respectively), whereas Somalia and Nigeria received the greatest relative increases, of 878% and 768%, respectively. The total disbursements to reproductive, maternal, newborn, and child health to several recipient countries varied substantially from year to year. Funding to child health and maternal and newborn health has become increasingly targeted to recipient countries with higher mortality (table 3) . Similarly, funding to reproductive and sexual health appears increasingly correlated with higher HIV prevalence over time, whereas there is little change in the correlation between reproductive and sexual health funding and female life expectancy. At the end of the period, many countries with lower need were still receiving substantially more funding per person than other countries with higher need (appendix p 21).
As in previous years, almost all (99%) ODA+ to reproductive, maternal, newborn, and child health in 2013 was channelled as projects, rather than general or sectoral budget support or through pooled funding mechanisms (fi gure 4, appendix p 20). Funds to HIV continued to comprise the largest share of project funding to reproductive, maternal, newborn, and child health (28%), with almost all of these funds being general-population disbursements not earmarked to reproductive, maternal, newborn, and child health. Funding to immunisation constituted the next largest area of project funding (18%), followed by reproductive health funds (assigned equally between maternal and newborn health and reproductive and sexual health; 15%), and funding for general health-care systems (13%). The largest relative increase in disbursements over the period 2003-13 was for malaria and HIV funding, increasing 14-fold and eight-fold, respectively. Disbursements for immunisation activities also 
Discussion
This study extends previous Countdown tracking work by examining resource fl ows to reproductive and sexual health before 2009, providing an 11 year time series for reproductive, maternal, newborn, and child health, and incorporating changes to donors' previously reported data. Over the period 2003-13, donors increasingly prioritised the health sector within overall ODA+. ODA+ to reproductive, maternal, newborn, and child health increased at a similar rate to ODA+ to the health sector, with both more than tripling over the 11 year period. Over the period of analysis, children aged between 1 month and 5 years benefi ted from half of the funding to reproductive, maternal, newborn, and child health and from the largest increase in donor funding, which was driven by substantial increases in funding for malaria and immunisation projects. The trends in funding are also a function of the evolving landscape of donors globally, with the sizable growth in funding from global initiatives such as the Global Fund and GAVI in fi nancing malaria and HIV projects benefi ting reproductive, maternal, newborn, and child health. While funding to maternal and newborn health increased substantially over the period, this group benefi ted from smaller increases than did child health and reproductive and sexual health. There were sustained increases in health system strengthening, which is essential to overcome the bottlenecks in reproductive, maternal, newborn, and child health services. 20 The MDG fi nal report reported greater progress towards MDG 4 on child mortality than on MDG 5 on maternal mortality, 21 while post-neonatal child mortality has declined substantially faster than neonatal mortality in the poorest countries. 22 Further funding increases are needed to accelerate maternal and neonatal mortality reduction, while maintaining a high level of investment in child health. 23 Donors have been prioritising their aid fl ows to overall health and to reproductive, maternal, newborn, and child health towards priority countries, which had a much greater growth in related ODA+ over the past 11 years than non-priority countries. However, low and decreasing budget support and the high level of donor-driven project funding limit the potential for the strategic allocation of funds to national priorities. There is substantial volatility in year-on-year total disbursements to recipient countries, which might refl ect unpredictability in funding fl ows, or could result from funds for large multiyear projects being disbursed in a single year.
The apparent improvement in targeting of ODA+ to reproductive, maternal, newborn, and child health to countries with the greatest health needs is consistent with previous fi ndings on targeting of ODA to HIV. 10, 13, 24 These trends are encouraging, but should be interpreted cautiously. In previous studies, we considered whether aid was targeted, reporting improvements in targeting at three timepoints. This was done by means of a series of linear regressions considering the size of the coeffi cient together with that of the R² as an indicator of the degree of targeting, where larger values were interpreted as corresponding to greater targeting. 10, 11 However, with an 11 year time series, such analyses would be inappropriate as the error terms in a series of univariate regressions would be auto-correlated, leading to a biased coeffi cient. A systematic assessment of the association between aid and recipient-country need and other characteristics, with the use of more complex econometric models to adjust for auto-correlation, would be an important area for future research. Moreover, improved targeting at the global level guarantees neither appropriate funding to priority needs at the national level, nor appropriate subnational distribution of funds.
Our consistency checks, updating of the underlying data, and recoding to include estimates for reproductive and sexual health before 2009, have led us to revise reported estimates for the years 2003-12. For example, our estimates for 2011 and 2012 are lower than previously reported 10 for ODA+ to reproductive and sexual health and to child health mainly because of corrections we made to coding after the consistency check of historical data which showed that in the past some records relating to food and humanitarian aid were coded as basic health care; these ought to have been excluded according to our coding scheme. Changes to donor reporting of project descriptions led to some changes. For some donors, our estimates exceeded those previously reported, largely because donors retrospectively added projects to the database. For example, we observed an eight-fold increase in the number of projects reported for maternal, newborn, and child health for the years 2004 and 2005 by Norway in 2015 compared with when these years were initially coded, and a 260% increase in the disbursement value to maternal, newborn, and child health. For some donors, all or nearly all of the disbursements for years 2003-12 were added retrospectively.
Our estimates of donor assistance to maternal, newborn, and child health are $0·4 billion lower than the IHME estimates for the year 2013 of $9·7 billion (in 2013 prices). However, IHME estimated a much lower increase in maternal, newborn, and child health funding over the period 2003-13, 93% compared with our estimate of 242%, which we attribute to important underlying diff erences in the concepts measured. The Partnership for Maternal, Newborn and Child Health estimated total offi cial development assistance to reproductive, maternal, newborn, and child health among the 75 priority countries at $12·1 billion (in 2013 prices), $1 billion less than estimated here, an increase of 116% between 2006 and 2013, compared with our estimate of 127% over that period. UNFPA and the Netherlands Interdisciplinary Demographic Institute estimated international population assistance at $11·0 billion in 2012, a 163% increase relative to 2003. 9 Their defi nition of population activities includes the components of reproductive, maternal, and newborn 25 tracked ODA to reproductive health between 2002 and 2011 and found a 298% increase in 18 confl ict-aff ected countries, which they contrasted with a 323% increase in 36 nonconfl ict-aff ected least developed countries over the same period. In December, 2014, the Organisation for Economic Co-operation and Development introduced a policy marker for reproductive, maternal, newborn, and child health, which donors can voluntarily use to mark their disbursements as contributing to reproductive, maternal, newborn, and child health. As of March 2016, only half of donors had reported on this policy marker for 2013, and so no time trends were available.
The various approaches to resource tracking diff er substantially in their coding methods-Countdown used manual review, IHME used automated key-term searches, and the Partnership for Maternal, Newborn and Child Health used the purpose codes reported by donors to the creditor reporting system. Given these diff erences, the similarity of the Countdown and IHME estimates for maternal, newborn, and child health might be a coincidence. We report elsewhere a detailed comparison of the methods used by the Countdown, IHME, and the Partnership for Maternal, Newborn and Child Health initiatives, and the creditor reporting system purpose codes and reproductive, maternal, newborn, and child health policy marker, commenting on their respective strengths and making recommendations for future tracking exercises (unpublished).
Our analysis has several limitations. Our method of manual coding relies on human interpretation of a coding scheme, which makes it diffi cult to replicate because it is subjective and highly labour-intensive. It is also dependent on the way donors describe projects, and on changes made to such descriptions over time. In some cases, projects that were previously described as being relevant to reproductive, maternal, newborn, and child health by donors, and included in our Countdown estimates, were subsequently modifi ed within the creditor reporting system database by donors, such that they no longer were eligible for a Countdown code. Additionally, diff erent people undertook the coding over time, which might have introduced bias. We hope to have minimised this through our standard coding framework and the consistency checks done in the data preparation. Our approach to allocating disbursements where the recipient was "bilateral, unspecifi ed" or was a region might not give entirely accurate results for each recipient, but to exclude these would have led to a large underestimate of ODA+ to reproductive, maternal, newborn, and child health. It is very unlikely that such disbursements were distributed by recipient such as to change the interpretation. More broadly, external funding to reproductive, maternal, newborn, and child health is only one source of countrylevel funds. Maintenance of gains already made, and further improvements in health outcomes, also depend on domestic funding and out-of-pocket expenditures, including remitted money, 26 which are not included in this study but are important for funding health systems across the world. Country case studies have reported on domestic fi nancing levels to reproductive, maternal, newborn, and child health in some of the Countdown priority countries. 23, 27, 28 In addition to reporting on trends in ODA+, it is also important to consider how disbursements refl ect aid eff ectiveness principles. Recent initiatives, including Every Woman Every Child, refer to reproductive, maternal, newborn, child, and adolescent health. While aspects of adolescent reproductive and sexual health are included in our coding framework, future resource-tracking work could include a wider range of adolescent health activities. considerable concern. Systematic comparison of the available tracking methods will help to identify an optimum approach in terms of timeliness and accuracy going forward, and this has been investigated in another study (unpublished).
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The sustained increase in reproductive, maternal, newborn, and child health funding over the period 2003-13, and possible improved targeting to need, is encouraging. However, substantial unexplained variation between countries remains and further research is needed to assess whether these increases are eff ective in improving health outcomes. 29 Donor reporting to the creditor reporting system has improved over time, perhaps in response to tracking exercises, which is encouraging, but it is important that further eff orts are made to ensure donors report accurate, complete, consistent, and timely data. Changes to the way donors describe and label projects aff ects whether they are coded as benefi ting reproductive, maternal, newborn, and child health. Major discrepancies between diff erent published estimates is a cause of 
